Using this discovery set of high-confidence RB1-proficient and RB1-defective samples, a subsampling-driven robust differential mRNA abundance analysis was performed between these two groups resulting in an RBness signature (RBNSig) of breast cancer (BC) (fig. The gene discussed is RB1; the disease is breast cancer.